A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope

Heart Rhythm

Volumn 5, Issue 11, 2008, Pages 1577-1586

  Christé, Georges ^a   Thériault, Olivier ^b   Chahine, Mohamed ^b   Millat, Gilles ^c,d   Rodriguez Lafrasse, Claire ^c,d   Rousson, Robert ^c   Deschênes, Isabelle ^e   Ficker, Eckhard ^e   Chevalier, Philippe ^d,f  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e METROHEALTH MEDICAL CENTER   (United States)

^f LOUIS PRADEL HOSPITAL   (France)

Author keywords

Congenital defects; human ether go go; K channel; Long QT syndrome; Sudden death; Ventricular arrhythmias

Indexed keywords

ALANINE; POTASSIUM CHANNEL HERG;

ADULT; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE DEPOLARIZATION; CELL STRAIN COS7; CONTROLLED STUDY; EMBRYO; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HEART MUSCLE POTENTIAL; HUMAN; HUMAN CELL; LONG QT SYNDROME; MUTATIONAL ANALYSIS; NONHUMAN; OOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SEDIMENTATION; WESTERN BLOTTING; WHOLE CELL; WILD TYPE; XENOPUS;

EID: 55249088583     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.08.031     Document Type: Article

References (27)

1. Lehnart S.E., Ackerman M.J., Benson Jr. D.W., et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 116 (2007) 2325-2345
2. Saenen J.B., and Vrints C.J. Molecular aspects of the congenital and acquired long QT syndrome: clinical implications. J Mol Cell Cardiol 44 (2008) 633-646
3. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
4. Moss A.J., and Kass R.S. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115 (2005) 2018-2024
5. Kass R.S., and Moss A.J. Mutation-specific pharmacology of the long QT syndrome. Handb Exp Pharmacol 171 (2006) 287-304
6. Napolitano C., Bloise R., and Priori S.G. Gene-specific therapy for inherited arrhythmogenic diseases. Pharmacol Ther 110 (2006) 1-13
7. Benitah J.P., Gomez A.M., Bailly P., et al. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol 469 (1993) 111-138
8. Chahine M., Chen L.Q., Barchi R.L., et al. Lidocaine block of human heart sodium channels expressed in Xenopus oocytes. J Mol Cell Cardiol 24 (1992) 1231-1236
9. Roti Roti E.C., Myers C.D., Ayers R.A., et al. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-a-go-go-related gene. J Biol Chem 277 (2002) 47779-47785
10. Pasek M., Simurda J., Orchard C.H., et al. A model of the guinea-pig ventricular cardiomyocyte incorporating a transverse-axial tubular system. Prog Biophys Mol Biol 96 (2008) 258-280
11. + current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res 77 (1995) 140-152
12. Wang S., Liu S., Morales M.J., Strauss H.C., and Rasmusson R.L. A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol 502 (1997) 45-60
13. + currents. Am J Physiol 291 (2006) C165-C175
14. Millat G., Chevalier P., Restier-Miron L., et al. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 70 (2006) 214-227
15. Spector P.S., Curran M.E., Zou A., et al. Fast inactivation causes rectification of the IKr channel. J Gen Physiol 107 (1996) 611-619
16. Sun Z., Milos P.M., Thompson J.F., et al. Role of a KCNH2 polymorphism (R1047L) in dofetilide-induced torsades de pointes. J Mol Cell Cardiol 37 (2004) 1031-1039
17. Zhou Z., Gong Q., Ye B., et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74 (1998) 230-241
18. Priori S. Inherited arrhythmias database. http://www.fsm.it/cardmoc/2007 Accessed August 28, 2008
19. Gong Q., Keeney D.R., Robinson J.C., et al. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome. J Mol Cell Cardiol 37 (2004) 1225-1233
20. Anderson C.L., Delisle B.P., Anson B.D., et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113 (2006) 365-373
21. Zhou Z., Gong Q., Epstein M.L., et al. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem 273 (1998) 21061-21066
22. Ficker E., Obejero-Paz C.A., Zhao S., et al. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. J Biol Chem 277 (2002) 4989-4998
23. Sanguinetti M.C., Curran M.E., Spector P.S., et al. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 93 (1996) 2208-2212
24. Kagan A., Yu Z., Fishman G.I., et al. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem 275 (2000) 11241-11248
25. Aydar E., and Palmer C. Functional characterization of the C-terminus of the human ether-a-go-go-related gene K(+) channel (HERG). J Physiol 534 (2001) 1-14
26. Choe C.U., Schulze-Bahr E., Neu A., et al. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon. Hum Mol Genet 15 (2006) 2888-2902
27. Sasano T., Ueda K., Orikabe M., et al. Novel C-terminus frameshift mutation, 1122fs/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation. J Mol Cell Cardiol 37 (2004) 1205-1211